COLLEGIUM PHARMACEUTICAL, INC

By person

28 insiders · 194 transactions

There is no salary here to measure against. COLLEGIUM PHARMACEUTICAL, INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Heffernan Michael Thomas

Director

—

$25.73M (43) scheduled

−$25.73M

50,328

0.1546%

$1.71M

−90.9%

Hirsch David

Director

—

$18.08M (4)

−$18.08M

3,116,956

9.57%

$106.13M

−24.6%

Longitude Capital Partners, LLC entity

10% owner

—

$17.34M (2)

−$17.34M

2,321,842

7.13%

$79.06M

−30.1%

Ciaffoni Joseph

President and CEO

—

$16.93M (40) scheduled

−$16.93M

444,867

1.37%

$15.15M

—

Dreyer Scott

EVP & Chief Commercial Officer

—

$11.58M (31) scheduled

−$11.58M

71,770

0.2205%

$2.44M

—

Kuhlmann Shirley R.

EVP and General Counsel

—

$7.72M (19) scheduled

−$7.72M

108,137

0.3322%

$3.68M

—

Tupper Colleen

EVP & Chief Financial Officer

—

$3.39M (11) scheduled

−$3.39M

147,282

0.4524%

$5.01M

+2,004%

Fleming Alison B

EVP & Chief Technical Officer

—

$1.94M (19) scheduled

−$1.94M

143,694

0.4414%

$4.89M

+1,893%

Fallon John A.

Director

—

$1.65M (1) scheduled

−$1.65M

64,634

0.1985%

$2.20M

+2,621%

BOHLIN GAREN G

Director

—

$1.26M (2) scheduled

−$1.26M

71,000

0.2181%

$2.42M

—

Smith Thomas B

EVP and Chief Medical Officer

—

$1.06M (3)

−$1.06M

90,651

0.2784%

$3.09M

+3,493%

Rubric Capital Management LP entity

10% owner

—

$946.25K (1)

−$946.25K

3,132,743

9.62%

$106.67M

−0.8%

Freund John Gordon

Director

—

$746.02K (4)

−$746.02K

1,335,400

4.10%

$45.47M

−68.0%

Dieter David

EVP & General Counsel

—

$716.21K (2) scheduled

−$716.21K

77,071

0.2367%

$2.62M

+733.7%

SANTINI GINO

Director

—

$201.02K (1) scheduled

−$201.02K

112,483

0.3455%

$3.83M

+385.1%

Brannelly Paul

Executive Vice President & CFO

$91.80K (1)

$279.17K (2)

−$187.37K

215,428

0.6617%

$7.34M

+158.4%

Balice-Gordon Rita J.

Director

—

$171.67K (1)

−$171.67K

61,370

0.1885%

$2.09M

—

Lurker Nancy

Director

—

$161.86K (1)

−$161.86K

26,758

0.0822%

$911.11K

—

KANEKO YASUNORI

10% owner

—

2,150,186

6.60%

$73.21M

−27.1%

Skyline Venture Partners V LP entity

10% owner

—

2,149,916

6.60%

$73.20M

−27.1%

Karnani Vikram

President and CEO

—

197,864

0.6078%

$6.74M

+52,523%

Malamut Richard

EVP and Chief Medical Officer

—

130,264

0.4001%

$4.44M

—

Melincoff Gwen A

Director

—

52,468

0.1612%

$1.79M

—

McFarlane Neil F.

Director

—

49,365

0.1516%

$1.68M

—

Paya Carlos V

Director

—

28,323

0.0870%

$964.40K

—

Duke Barry S

See remarks

—

20,087

0.0617%

$683.96K

+241.0%

Glancy Donovan Michael

Director

—

17,482

0.0537%

$595.26K

—

Schroeder Theodore R

Director

—

11,007

0.0338%

$374.79K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Freund John Gordon

15 May 2026

Director

Sold after exercise

4,127

$34.54

$142.55K

BOHLIN GAREN G

11 May 2026

Director

Sold after exercise

8,700

$37.18

$323.49K

Dreyer Scott

8 Dec 2025

EVP & Chief Commercial Officer

Sold after exercise

6,475

$48.66

$315.08K

Dreyer Scott

8 Dec 2025

EVP & Chief Commercial Officer

Sold after exercise

11,125

$47.89

$532.77K

Fallon John A.

12 Nov 2025

Director

Sold after exercise

34,853

$47.21

$1.65M

Dreyer Scott

18 Aug 2025

EVP & Chief Commercial Officer

Sold after exercise

16,389

$38.21

$626.17K

SANTINI GINO

15 Aug 2025

Director

Sold after exercise

5,405

$37.19

$201.02K

Dreyer Scott

13 Aug 2025

EVP & Chief Commercial Officer

Sold after exercise

4,861

$38.03

$184.88K

Freund John Gordon

9 Jun 2025

Director

Sold after exercise

6,601

$30.62

$202.15K

Kuhlmann Shirley R.

4 Mar 2025

EVP and General Counsel

Sold after exercise

40,000

$28.08

$1.12M

Kuhlmann Shirley R.

10 Jan 2025

EVP and General Counsel

Sold after exercise

6,100

$33.64

$205.22K

Kuhlmann Shirley R.

10 Jan 2025

EVP and General Counsel

Sold after exercise

21,400

$32.87

$703.41K

Dreyer Scott

24 May 2024

EVP & Chief Commercial Officer

Sold after exercise

56,807

$33.98

$1.93M

Dreyer Scott

23 May 2024

EVP & Chief Commercial Officer

Sold after exercise

51,209

$33.82

$1.73M

BOHLIN GAREN G

14 May 2024

Director

Sold after exercise

28,985

$32.30

$936.31K

Ciaffoni Joseph

21 Dec 2023

President and CEO

Sold after exercise

4,357

$30.38

$132.38K

Ciaffoni Joseph

20 Dec 2023

President and CEO

Sold after exercise

26,454

$30.40

$804.21K

Ciaffoni Joseph

19 Dec 2023

President and CEO

Sold after exercise

14,516

$30.03

$435.94K

Ciaffoni Joseph

18 Dec 2023

President and CEO

Sold after exercise

27,798

$30.04

$834.94K

Kuhlmann Shirley R.

27 Nov 2023

EVP and General Counsel

Sold after exercise

25,600

$25.78

$660.01K

Ciaffoni Joseph

13 Feb 2023

President and CEO

Sold after exercise

11,250

$26.88

$302.40K

Heffernan Michael Thomas

27 Dec 2022

Director

Sold after exercise

3,820

$24.16

$92.29K

Heffernan Michael Thomas

27 Dec 2022

Director

Sold after exercise

15,995

$23.63

$377.96K

Heffernan Michael Thomas

23 Dec 2022

Director

Sold after exercise

4,989

$23.00

$114.75K

Heffernan Michael Thomas

22 Dec 2022

Director

Sold after exercise

237

$23.00

$5.45K

Heffernan Michael Thomas

21 Dec 2022

Director

Sold after exercise

46,600

$23.11

$1.08M

Heffernan Michael Thomas

20 Dec 2022

Director

Sold after exercise

33,758

$23.08

$779.13K

Heffernan Michael Thomas

19 Dec 2022

Director

Sold after exercise

3,606

$23.04

$83.08K

Heffernan Michael Thomas

13 Dec 2022

Director

Sold after exercise

161,687

$22.16

$3.58M

Heffernan Michael Thomas

12 Dec 2022

Director

Sold after exercise

27,920

$22.01

$614.52K

Ciaffoni Joseph

1 Dec 2022

President and CEO

Sold after exercise

76,653

$22.47

$1.72M

Ciaffoni Joseph

28 Nov 2022

President and CEO

Sold after exercise

$22.00

$946.00

Ciaffoni Joseph

22 Nov 2022

President and CEO

Sold after exercise

$22.00

$1.43K

Ciaffoni Joseph

18 Nov 2022

President and CEO

Sold after exercise

1,989

$22.02

$43.80K

Ciaffoni Joseph

1 Jun 2021

President and CEO

Sold after exercise

10,829

$23.33

$252.64K

Ciaffoni Joseph

1 Jun 2021

President and CEO

Sold after exercise

5,376

$22.93

$123.27K

Ciaffoni Joseph

1 Mar 2021

President and CEO

Sold after exercise

9,809

$23.30

$228.55K

Ciaffoni Joseph

1 Mar 2021

President and CEO

Sold after exercise

54,959

$22.56

$1.24M

Fleming Alison B

7 Jan 2021

Chief Technology Officer

Sold after exercise

16,042

$22.00

$352.92K

Ciaffoni Joseph

1 Jun 2020

President and CEO

Sold after exercise

100

$22.08

$2.21K

Ciaffoni Joseph

1 Jun 2020

President and CEO

Sold after exercise

70,576

$21.53

$1.52M

Dreyer Scott

18 May 2020

EVP & Chief Commercial Officer

Sold after exercise

8,000

$24.00

$192.00K

Heffernan Michael Thomas

21 Jan 2020

Director

Sold after exercise

32,700

$22.69

$741.96K

Heffernan Michael Thomas

21 Jan 2020

Director

Sold after exercise

262,587

$21.84

$5.73M

Fleming Alison B

8 Nov 2019

Chief Technology Officer

Sold after exercise

25,000

$19.44

$486.00K

Ciaffoni Joseph

7 Nov 2019

President and CEO

Sold after exercise

31,226

$19.16

$598.29K

Ciaffoni Joseph

7 Nov 2019

President and CEO

Sold after exercise

33,595

$18.41

$618.48K

Hirsch David

29 Aug 2019

Director

Sold after exercise

22,106

$11.65

$257.53K

Ciaffoni Joseph

31 May 2018

Chief Operating Officer

Sold after exercise

5,617

$23.35

$131.16K

Ciaffoni Joseph

31 May 2018

Chief Operating Officer

Sold after exercise

59,204

$22.54

$1.33M

Fleming Alison B

19 Jan 2018

Chief Technology Officer

Sold after exercise

3,336

$23.00

$76.73K

Fleming Alison B

19 Jan 2018

Chief Technical Officer

Sold after exercise

1,449

$23.00

$33.33K

Fleming Alison B

19 Jan 2018

Chief Technical Officer

Sold after exercise

1,811

$23.00

$41.65K

Fleming Alison B

19 Jan 2018

Chief Technical Officer

Sold after exercise

$23.00

$1.47K

Fleming Alison B

12 Jan 2018

Chief Technical Officer

Sold after exercise

5,753

$21.00

$120.81K

Fleming Alison B

12 Jan 2018

Chief Technical Officer

Sold after exercise

1,747

$21.00

$36.69K

Fleming Alison B

10 Jan 2018

Chief Technology Officer

Sold after exercise

6,928

$19.07

$132.12K

Fleming Alison B

21 Nov 2017

Chief Technology Officer

Sold after exercise

572

$19.00

$10.87K

Fleming Alison B

17 Nov 2017

Chief Technology Officer

Sold after exercise

840

$17.00

$14.28K

Fleming Alison B

17 Nov 2017

Chief Technology Officer

Sold after exercise

1,239

$17.00

$21.06K

Fleming Alison B

17 Nov 2017

Chief Technology Officer

Sold after exercise

1,950

$17.00

$33.15K

Show all 194 transactions →

COLLEGIUM PHARMACEUTICAL, INC

By person

Individual transactions

What was left out